Cambium Bio Ltd
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.260 AUD
−3.84 M AUD
670.06 K AUD
19.22 M
About Cambium Bio Ltd
Sector
Industry
CEO
Karolis Rosickas
Headquarters
Bella Vista
Identifiers
2
ISINAU0000327769
Cambium Bio Ltd. engages in the development and commercialization of regenerative therapies derived from novel processed human platelets. The company is headquartered in Paddington, Australia.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CMB is 0.465 AUD — it has decreased by −1.06% in the past 24 hours. Watch Cambium Bio Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange Cambium Bio Ltd stocks are traded under the ticker CMB.
CMB stock has fallen by −1.06% compared to the previous week, the month change is a −7.92% fall, over the last year Cambium Bio Ltd has showed a 9.41% increase.
CMB stock is 1.08% volatile and has beta coefficient of −0.62. Track Cambium Bio Ltd stock price on the chart and check out the list of the most volatile stocks — is Cambium Bio Ltd there?
Yes, you can track Cambium Bio Ltd financials in yearly and quarterly reports right on TradingView.
Cambium Bio Ltd is going to release the next earnings report on Feb 26, 2026. Keep track of upcoming events with our Earnings Calendar.
CMB net income for the last half-year is −2.12 M AUD, while the previous report showed −1.73 M AUD of net income which accounts for −22.74% change. Track more Cambium Bio Ltd financial stats to get the full picture.
No, CMB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CMB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cambium Bio Ltd stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cambium Bio Ltd technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cambium Bio Ltd stock shows the sell signal. See more of Cambium Bio Ltd technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.